1. Home
  2. CTRN vs LCTX Comparison

CTRN vs LCTX Comparison

Compare CTRN & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citi Trends Inc.

CTRN

Citi Trends Inc.

HOLD

Current Price

$45.28

Market Cap

382.6M

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.59

Market Cap

391.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRN
LCTX
Founded
1946
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
382.6M
391.1M
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
CTRN
LCTX
Price
$45.28
$1.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$52.00
$5.33
AVG Volume (30 Days)
92.5K
1.0M
Earning Date
06-02-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$753,079,000.00
$14,556,000.00
Revenue This Year
$7.76
$109.40
Revenue Next Year
$5.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.69
53.24
52 Week Low
$18.75
$0.40
52 Week High
$56.78
$2.09

Technical Indicators

Market Signals
Indicator
CTRN
LCTX
Relative Strength Index (RSI) 51.03 51.14
Support Level $42.06 $1.56
Resistance Level $48.59 $1.82
Average True Range (ATR) 2.81 0.07
MACD 0.17 0.01
Stochastic Oscillator 49.02 70.00

Price Performance

Historical Comparison
CTRN
LCTX

About CTRN Citi Trends Inc.

Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States. The company offers apparel, including fashion sportswear for men and women, as well as children, such as newborns, infants, toddlers, boys, and girls; accessories comprising handbags, jewelry, footwear, belts, intimate apparel, scrubs, and sleepwear; and functional and decorative home products, as well as beauty products, books and toys.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: